186 related articles for article (PubMed ID: 36298835)
21. Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response.
Cheung NN; Lai KK; Dai J; Kok KH; Chen H; Chan KH; Yuen KY; Kao RYT
J Gen Virol; 2017 May; 98(5):946-954. PubMed ID: 28555543
[TBL] [Abstract][Full Text] [Related]
22. A novel series of teriflunomide derivatives as orally active inhibitors of human dihydroorotate dehydrogenase for the treatment of colorectal carcinoma.
Li C; Zhou Y; Xu J; Zhou X; Huang Z; Zeng T; Yang X; Tao L; Gou K; Zhong X; Chen Q; Luo Y; Zhao Y
Eur J Med Chem; 2022 Aug; 238():114489. PubMed ID: 35640328
[TBL] [Abstract][Full Text] [Related]
23. Dihydroorotate dehydrogenase inhibitors in anti-infective drug research.
Boschi D; Pippione AC; Sainas S; Lolli ML
Eur J Med Chem; 2019 Dec; 183():111681. PubMed ID: 31557612
[TBL] [Abstract][Full Text] [Related]
24. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
[TBL] [Abstract][Full Text] [Related]
25. Salvage capacity of hepatoma 3924A and action of dipyridamole.
Weber G; Lui MS; Natsumeda Y; Faderan MA
Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
Wang QY; Bushell S; Qing M; Xu HY; Bonavia A; Nunes S; Zhou J; Poh MK; Florez de Sessions P; Niyomrattanakit P; Dong H; Hoffmaster K; Goh A; Nilar S; Schul W; Jones S; Kramer L; Compton T; Shi PY
J Virol; 2011 Jul; 85(13):6548-56. PubMed ID: 21507975
[TBL] [Abstract][Full Text] [Related]
27. Discovery and Optimization of Novel
Zhou X; Gou K; Xu J; Jian L; Luo Y; Li C; Guan X; Qiu J; Zou J; Zhang Y; Zhong X; Zeng T; Zhou Y; Xiao Y; Yang X; Chen W; Gao P; Liu C; Zhou Y; Tao L; Liu X; Cen X; Chen Q; Sun Q; Luo Y; Zhao Y
J Med Chem; 2023 Nov; 66(21):14755-14786. PubMed ID: 37870434
[TBL] [Abstract][Full Text] [Related]
28. The Cranberry Extract Oximacro
Luganini A; Terlizzi ME; Catucci G; Gilardi G; Maffei ME; Gribaudo G
Front Microbiol; 2018; 9():1826. PubMed ID: 30131793
[TBL] [Abstract][Full Text] [Related]
29. Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro.
Kim YJ; Cubitt B; Cai Y; Kuhn JH; Vitt D; Kohlhof H; de la Torre JC
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751087
[TBL] [Abstract][Full Text] [Related]
30. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis.
Hoffmann HH; Kunz A; Simon VA; Palese P; Shaw ML
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5777-82. PubMed ID: 21436031
[TBL] [Abstract][Full Text] [Related]
31. Original Chemical Series of Pyrimidine Biosynthesis Inhibitors That Boost the Antiviral Interferon Response.
Lucas-Hourani M; Dauzonne D; Munier-Lehmann H; Khiar S; Nisole S; Dairou J; Helynck O; Afonso PV; Tangy F; Vidalain PO
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28807907
[No Abstract] [Full Text] [Related]
32. Discovery a series of novel inhibitors of human dihydroorotate dehydrogenase: Biological activity evaluation and molecular docking.
Ren X; Liu X; Hua M; Dai Y; Ren X; Sui C; Li X; Jiang Z; Tian M; Yang B
Chem Biol Drug Des; 2024 Jan; 103(1):e14388. PubMed ID: 37926553
[TBL] [Abstract][Full Text] [Related]
33. Discovery of a novel series of hDHODH inhibitors with anti-pulmonary fibrotic activities.
Lu K; Zhao Y; Wu G; Hu H; Wang M; Gong G; Jiang Y
Bioorg Chem; 2019 May; 86():44-51. PubMed ID: 30685643
[TBL] [Abstract][Full Text] [Related]
34. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
Front Immunol; 2019; 10():60. PubMed ID: 30761132
[TBL] [Abstract][Full Text] [Related]
35. Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis.
Marschall M; Niemann I; Kosulin K; Bootz A; Wagner S; Dobner T; Herz T; Kramer B; Leban J; Vitt D; Stamminger T; Hutterer C; Strobl S
Antiviral Res; 2013 Dec; 100(3):640-8. PubMed ID: 24149002
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells.
Lafita-Navarro MC; Venkateswaran N; Kilgore JA; Kanji S; Han J; Barnes S; Williams NS; Buszczak M; Burma S; Conacci-Sorrell M
PLoS Genet; 2020 Nov; 16(11):e1009117. PubMed ID: 33201894
[TBL] [Abstract][Full Text] [Related]
37. Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy.
Lolli ML; Sainas S; Pippione AC; Giorgis M; Boschi D; Dosio F
Recent Pat Anticancer Drug Discov; 2018; 13(1):86-105. PubMed ID: 29119937
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis.
Chen SF; Ruben RL; Dexter DL
Cancer Res; 1986 Oct; 46(10):5014-9. PubMed ID: 3019518
[TBL] [Abstract][Full Text] [Related]
39. Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.
Sainas S; Pippione AC; Lupino E; Giorgis M; Circosta P; Gaidano V; Goyal P; Bonanni D; Rolando B; Cignetti A; Ducime A; Andersson M; Järvå M; Friemann R; Piccinini M; Ramondetti C; Buccinnà B; Al-Karadaghi S; Boschi D; Saglio G; Lolli ML
J Med Chem; 2018 Jul; 61(14):6034-6055. PubMed ID: 29939742
[TBL] [Abstract][Full Text] [Related]
40. Human pyrimidine nucleotide biosynthesis as a target for antiviral chemotherapy.
Okesli A; Khosla C; Bassik MC
Curr Opin Biotechnol; 2017 Dec; 48():127-134. PubMed ID: 28458037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
